Info
Schedule 13D
Ownership

Frazier Life Sciences Public Fund, L.P. - Significant Ownership

Signature - Title: /s/ Steve R. Bailey - By Steve R. Bailey, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P., GP of Frazier Life Sciences Public Fund, L.P.
Location: Palo Alto, CA
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Frazier Life Sciences Public Fund, L.P..

Significant Ownership of Frazier Life Sciences Public Fund, L.P.

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
PHAT	PHATHOM PHARMACEUTICALS, INC.	Common Stock, $0.0001 par value per share	19.9%	$62.9M		14.4M		James N. Topper	May 9, 2025
TRVI	Trevi Therapeutics, Inc.	Common Stock, $0.001 par value per share	10.6%	$65.1M	-$2.57M	10.3M	-3.8%	James N. Topper	Mar 31, 2025
MAZE	Maze Therapeutics, Inc.	Common Stock, par value $0.001 per share	10.2%	$39.1M	$2.83M	4.45M	+7.81%	James N. Topper	Apr 25, 2025
AURA	Aura Biosciences, Inc.	Common Stock, $0.00001 par value per share	9.9%	$34.9M		6.32M		James N. Topper	May 16, 2025
LXEO	Lexeo Therapeutics, Inc.	Common Stock, $0.0001 par value per share	9.9%	$16.4M		5.5M		James N. Topper	May 28, 2025
XLO	Xilio Therapeutics, Inc.	Common Stock, par value $0.0001 per share	9.9%	$6.61M		5.75M		James N. Topper	Jun 5, 2025
ERAS	Erasca, Inc.	Common Stock, $0.0001 par value per share	8%	$31.4M		22.6M		James N. Topper	Mar 31, 2025
SVRA	Savara Inc.	Common Stock, par value $0.001 per share	6.6%	$36.5M		11.5M		James N. Topper	Mar 31, 2025
PVLA	Palvella Therapeutics, Inc.	Common Stock, par value $0.001 per share	6.3%	$16.2M	$2.67M	690K	+19.8%	James N. Topper	Mar 31, 2025
JBIO	JADE BIOSCIENCES, INC.	Common stock, par value $0.0001 per share	5.5%	$18M		1.77M		James N. Topper	Apr 28, 2025
MREO	Mereo BioPharma Group plc	Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares	5.1%	$105M		40.3M		James N. Topper	Apr 1, 2025
ORIC	ORIC Pharmaceuticals, Inc.	Common Stock, $0.0001 par value per share	2%	$7.98M		1.41M		James N. Topper	Mar 31, 2025
ELDN	Eledon Pharmaceuticals, Inc.	Common Stock	2%	$3.85M		1.18M		James N. Topper	Dec 31, 2024
ANAB	AnaptysBio, Inc.	Common Stock	0.5%					Frazier Life Sciences Public Fund, L.P.	Jan 31, 2025
PBYI	Puma Biotechnology, Inc.	Common Stock	0%	$0		0		Frazier Life Sciences Public Fund, L.P.	Dec 31, 2024
ANTX	AN2 THERAPEUTICS, INC.	Common Stock	0%	$0		0		Frazier Life Sciences Public Fund, L.P.	Dec 31, 2024

Showing 1 to 16 of 16 entries

Schedules 13D/G Reported by Frazier Life Sciences Public Fund, L.P.:

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.